Molecular Moments
Molecular Moments Podcast
Playlist by Molecular MomentsWelcome to the Molecular Moments podcast hosted by the scientific experts at BioAgilytix Labs! Whether you’re curious about what goes on at BioAgilytix or about the folks behind the lab coats, we’ve f…Follow the podcast:
26 clip(s) in playlist
Drs. Shashank Gorityala, Ben Nie, and Amanda Hays talk LC/MS bioanalysis, platforms, matrices, workflows, and regulations.
On this episode of Molecular Moments, Dr. Amanda Hays chats with BioAgilytix scientists Dr. Shashank Gorityala, Associate Director of LC/MS Operations from our Durham lab, and Dr. Ben Nie, Scientist III from our San Diego lab. They delve into LC/MS evolution, tech strides, and its role in large mol…
46:24
Adam Stasio Talks, Large Data Sets, Breaking Down Problems, and Tech-Driven Solutions
On this episode of Molecular Moments, Jim McNally, Ph.D., speaks with Adam Stasio, president of SciMed, whose mission is to craft software that frees their clients to do what they do best: advance cutting-edge technology, improve lives, and effect social change. They discuss their shared passion fo…
41:00
Dr. David Berkowitz Talks Enzymes, Radiation, and the Lincoln Marathon
On this episode of Molecular Moments, Chad Briscoe speaks with Dr. David Berkowitz, Director of the Division of Chemistry at the National Science Foundation (NSF) and a Willa Cather Professor of Chemistry at the University of Nebraska-Lincoln, and co-lead of the Nebraska Drug Discovery & Developmen…
45:01
Rick Briscoe Talks Neuroscience, Safety Pharmacology, and Scuba Diving!
On this episode of Molecular Moments, Chad Briscoe talks with his brother, Rick Briscoe, Senior VP of Safety Assessment and Research Operations at Cerevel Therapeutics. Rick talks with Chad about how he found his love of the sciences through a scuba diving class in high school, which sparked his …
37:37
Stephanie Pasas-Farmer Talks Chemistry, the Future of AI in Bioanalysis, and the Joy of Cooking!
On this episode of Molecular Moments, BioAgilytix Scientific Officers Amanda Hays, Ph.D., and Lynn Kamen, Ph.D. speak with Stephanie Pasas-Farmer, Ph.D., President of both Ariadne Software and BioData Solutions. They discuss how Stephanie went from a career as a bioanalytical chemist to being an e…
32:58
Lynn Kamen and Michelle Miller Talk Bioanalysis: Past, Present, and Future
On this episode of Molecular Moments, Lynn Kamen, Ph.D., and Michelle Miller, Ph.D. DABT discuss their very different journeys to BioAgilytix as Scientific Officers. Despite different initial career paths, they both ended up working in bioanalysis, supporting the development of novel therapeutics. …
33:21
Dr. David Johnson Talks Frosted Flakes, Small Molecules, and Pharmacokinetics!
On this episode of Molecular Moments, Dr. Jim McNally chats with DMPK Senior Director Dr. David Johnson, Ph.D., from BioAgilytix San Diego. They discuss how his childhood breakfast cereal formed an interest in science which eventually led to his pursuit of biochemistry and a career in small molecul…
35:57
Tricia Sterling Talks Rare Diseases, Trust, and Advocacy
In this episode of Molecular Moments, Dr. Jim McNally chats with Tricia Sterling, Vice President of Patient Affairs at Aeglea. Tricia shares some of her experiences working with patients in the biotech industry for over a decade. Jim and Tricia’s discussion focuses on the patient side of pharmaceu…
35:48
Dr. Dave Williams Talks Flow Cytometers, Harmony, and KC BBQ!
On this episode of Molecular Moments, Scientific Officer Amanda Hayes speaks with BioAgilytix colleague Dr. Dave Williams, Vice President of Operations. Dave has spent the last decade of his career supporting and leading bioanalytical programs at contract research organizations (CROs) in his pursui…
27:25
Dr. Kevin Bateman talks innovation, dried blood spots, and the LCS model!
On this episode of Molecular Moments, Dr. Chad Briscoe is joined by Dr. Kevin Bateman, Scientific Associate and Vice President at Merck. Kevin is a veteran of the bioanalytical industry and is known for innovating and encouraging new technology research. With over 25 years at Merck, Kevin shares a …
45:13